123I-vasoactive intestinal peptide (VIP) receptor scanning: Update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract

This publication has 26 references indexed in Scilit:

• Combined use of 111in-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC)
  Nuclear Medicine and Biology, 1996
• Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐d‐Phe¹]‐Octreotide
  Annals of the New York Academy of Sciences, 1994
• Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal Domains
  Biochemical and Biophysical Research Communications, 1994
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin‐14 like peptides
  FEBS Letters, 1993
• VIP: Molecular biology and neurobiological function
  Molecular Neurobiology, 1989
• LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
  The Lancet, 1989
• The Human Vasoactive Intestinal Peptide Receptor: Molecular Identification by Covalent Cross-Linking in Colonic Epithelium*
  Journal of Clinical Endocrinology & Metabolism, 1985
• VASOACTIVE INTESTINAL PEPTIDE AND WATERY-DIARRHŒA SYNDROME
  The Lancet, 1973
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
  Science, 1973